Cerebral Palsy Market Size, Share & Growth | Forecast [2031]
Cerebral Palsy Market Size, Share & Growth | Forecast [2031]
Segments - Cerebral Palsy Market by Types (Ataxia Cerebral Palsy, Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Athetoid Cerebral Palsy, Postnatal Cerebral Palsy, Congenital Cerebral Palsy, Hemiparesis of Cerebral Palsy, Hypotonic Cerebral Palsy, and Diplegia of Cerebral Palsy), Treatments (Surgery, Medication, and Therapy), Diagnosis (Laboratory Tests, Imaging Tests, and Others), Medical Devices (Orthotic Devices, ENT Devices, and Eye-tracking Devices), End-users (Physiotherapy Centers, Hospitals, Specialty Clinics, Home Care, Pathology Centers, Ambulatory, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-4191
| 4.5 Rating
| 77 Reviews
| 177 Pages
| Format :
Report Description
The global cerebral palsy market size was valued at USD 3.38 Billion in 2023 and is expected to surpass USD 4.53 Billion by 2031, expanding at a CAGR of 3.3% during the forecast period, 2023–2031. The growth of the market is attributed to the rising healthcare expenditure for the infant population and availability of advanced treatment devices of cerebral palsy.
Cerebral palsy refers to a neurological disorder that primarily affects the coordination of body movement of an infant due to imbalance brain development before birth, during birth, or after birth. The disorder is widely prevailed among the infant population. An infant with the disorder has incapable to walk independently and unstable walking patterns due to disturbance in body balance, body motion, and body posture. Patients with cerebral palsy show symptoms of various physical disabilities and impairment such as vision or hearing impairment and seizures besides a severe case of intellectual impairment. It is primary caused by the immature brain development after birth or other factors such as severe jaundice, bleeding into the brain, and brain infections of an infant. Without a proper and timely treatment or therapy, a patient may result to permanent paralysis.
The number of patients suffering from the disorder is higher in developed countries. As per the report by the Cerebral Palsy Guidance, around 10,000 babies are born with cerebral palsy each year in the US. According to the data published by the National Institute for Health and Care Excellence (NICE) in 2017, nearly 1 in 400 babies are born with the cerebral palsy in the UK and approximately around 1,800 infants are diagnosed with the disorder every year. The COVID-19 pandemic had adversely affected the market due to increasing decline of the patients visit to hospitals for the treatment as the majority of healthcare organizations were totally focused on handling the virus spreading.
Market Trends, Drivers, Restraints, and Opportunities
-
High prevalence of cerebral palsy among infants, especially in developed countries present a key factor driving the market.
-
Rising awareness among parents about the medications and advanced treatment methods for the disorder are expected to fuel the market in the coming years.
-
High spending on the healthcare sector and wide availability for insurance coverage for the disease treatment further boost the market.
-
High cost of the device treatment and some side effects of using treatment medications are the main restraining factors that can hamper the market.
-
Extensive R&D programs and technology development for the development of innovative medicines and devices are projected to create several growth opportunities for the market during the forecast period.
Scope of the Report
The report on the global cerebral palsy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cerebral Palsy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Types (Ataxia Cerebral Palsy, Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Athetoid Cerebral Palsy, Postnatal Cerebral Palsy, Congenital Cerebral Palsy, Hemiparesis of Cerebral Palsy, Hypotonic Cerebral Palsy, and Diplegia of Cerebral Palsy), Treatments (Surgery, Medication, and Therapy), Diagnosis (Laboratory Tests, Imaging Tests, and Others), Medical Devices (Orthotic Devices, ENT Devices, and Eye-tracking Devices), End-users (Physiotherapy Centers, Hospitals, Specialty Clinics, Home Care, Pathology Centers, Ambulatory, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc. |
Market Segment Insights
Spastic cerebral palsy segment to expand at a rapid pace
Based on types, the global cerebral palsy market is divided into ataxia cerebral palsy, spastic cerebral palsy, dyskinetic cerebral palsy, athetoid cerebral palsy, postnatal cerebral palsy, congenital cerebral palsy, hemiparesis of cerebral palsy, hypotonic cerebral palsy, and diplegia of cerebral palsy. The spastic cerebral segment is expected to expand at a rapid pace during the forecast period as it is the most common type of the disorder occurred among the infants. As per global health reports, spastic cerebral type accounts for nearly 77% of all cerebral palsy cases worldwide.
Wide availability of treatment drugs fuels the medication segment
In terms of treatments, the market is segmented into surgery, medication, and therapy. The medication segment accounted for a large market share in 2021 and is anticipated to hold a key share of the market in the coming years owing to wide availability of drugs such as muscle relaxants drugs, anti-depressants drugs, anti-convulsant drugs, anti-inflammatory drugs, and anti-spastic drugs. Medication remains a key component of the disorder treatment as parents usually prefer to adopt medication treatment first. The options for therapy and surgery are generally considered after the medication treatment of the disorder is not improving or working with the patients.
Increasing demand for MRI, CT, and EEG boosts the imaging tests segment
On the basis of diagnosis, the global cerebral palsy market is classified as laboratory tests, imaging tests, and others. The imaging tests segment is anticipated to expand at a rapid pace during the forecast period owing to increasing demand for magnetic resonance imaging (MRI), computerized tomography (CT); ultrasound, and electroencephalogram (EEG). Moreover, the wide popularity of the imaging tests in diagnostic purposes due to its certain benefits such as accurate diagnostic results present another key driver of the segment.
ENT devices segment to exhibit a robust growth rate
Based on medical devices, the market is categorized as orthotic devices, ENT devices, and eye-tracking devices. The ENT devices segment accounted for a large market share in 2021 and is anticipated to exhibit a robust growth rate during the forecast period owing to rising demand for electronic communication boards and other ENT devices such as hearing aids and implants.
Rising patients’ admission to hospitals propels the hospitals segment
On the basis of end-users, the global cerebral palsy market is segregated into physiotherapy centers, hospitals, specialty clinics, home care, pathology centers, ambulatory, and others. The hospitals segment is projected to register a considerable CAGR during the forecast period owing to high admission of the patients to hospitals due to the wide availability of advanced treatment devices and the presence of specialized doctors for the disorder.
North America to constitute a key market share
In terms of regions, the global cerebral palsy market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share, representing more than 37% share of the total revenue of the market in 2021 and is expected to constitute a key share of the market during the projected period owing to high prevalence of the disorder among a large portion of the infant population, rising adoption of novel treatment devices, and increasing spending on health-related issues. Moreover, the presence of well-established healthcare infrastructure and favorable reimbursement policies from medical insurance companies further drive the regional market.
Segments
The global cerebral palsy market has been segmented on the basis of
Types
- Ataxia Cerebral Palsy
- Spastic Cerebral Palsy
- Dyskinetic Cerebral Palsy
- Athetoid Cerebral Palsy
- Postnatal Cerebral Palsy
- Congenital Cerebral Palsy
- Hemiparesis of Cerebral Palsy
- Hypotonic Cerebral Palsy
- Diplegia of Cerebral Palsy
Treatments
- Surgery
- Medication
- Therapy
Diagnosis
- Laboratory Tests
- Imaging Tests
- Others
Medical Devices
- Orthotic Devices
- ENT Devices
- Eye-tracking Devices
End-users
- Physiotherapy Centers
- Hospitals
- Specialty Clinics
- Home Care
- Pathology Centers
- Ambulatory
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- Allergen Plc
- Merck & Co., Inc.
- Medtronic PLC
- Cellular Biomedicine Group
- GlaxoSmithKline Plc
- Cell Cure Neurosciences Ltd.
- Acorda Therapeutics, Inc.
- Meridigen Biotech Co., Ltd.
- GW Pharmaceuticals Plc
- Pfizer, Inc.
Competitive Landscape
Key players competing in the global cerebral palsy market are Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc. Some of these players have adopted a series of business development strategies including merger and acquisition, entering into partnership and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.
Frequently Asked Questions
The key players of the market are Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc.
North America accounted for more than 37% share of the total revenue of the market in 2021 and is likely to dominate the market during the forecast period.
The hospitals segment is likely to constitute a key market share during the forecast period.
The key drivers of the market include the rising healthcare expenditure for the infant population and availability of advanced treatment devices of cerebral palsy.
The global cerebral palsy market size was valued at USD 3,270.1 million in 2021 and is expected to surpass USD 4365 million by 2030.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cerebral Palsy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cerebral Palsy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cerebral Palsy Market - Supply Chain
4.5. Global Cerebral Palsy Market Forecast
4.5.1. Cerebral Palsy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cerebral Palsy Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cerebral Palsy Market Absolute $ Opportunity
5. Global Cerebral Palsy Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Cerebral Palsy Market Size and Volume Forecast by Types
5.3.1. Ataxia Cerebral Palsy
5.3.2. Spastic Cerebral Palsy
5.3.3. Dyskinetic Cerebral Palsy
5.3.4. Athetoid Cerebral Palsy
5.3.5. Postnatal Cerebral Palsy
5.3.6. Congenital Cerebral Palsy
5.3.7. Hemiparesis of Cerebral Palsy
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cerebral Palsy Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Cerebral Palsy Market Size and Volume Forecast by End Users
6.3.1. Physiotherapy Centers
6.3.2. Hospitals
6.3.3. Specialty Clinics
6.3.4. Home Care
6.3.5. Pathology Centers
6.3.6. Ambulatory
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cerebral Palsy Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Cerebral Palsy Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Cerebral Palsy Demand Share Forecast, 2019-2026
8. North America Cerebral Palsy Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Cerebral Palsy Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Cerebral Palsy Market Size and Volume Forecast by Types
8.4.1. Ataxia Cerebral Palsy
8.4.2. Spastic Cerebral Palsy
8.4.3. Dyskinetic Cerebral Palsy
8.4.4. Athetoid Cerebral Palsy
8.4.5. Postnatal Cerebral Palsy
8.4.6. Congenital Cerebral Palsy
8.4.7. Hemiparesis of Cerebral Palsy
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Cerebral Palsy Market Size and Volume Forecast by End Users
8.7.1. Physiotherapy Centers
8.7.2. Hospitals
8.7.3. Specialty Clinics
8.7.4. Home Care
8.7.5. Pathology Centers
8.7.6. Ambulatory
8.7.7. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Cerebral Palsy Demand Share Forecast, 2019-2026
9. Latin America Cerebral Palsy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Cerebral Palsy Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Cerebral Palsy Market Size and Volume Forecast by Types
9.4.1. Ataxia Cerebral Palsy
9.4.2. Spastic Cerebral Palsy
9.4.3. Dyskinetic Cerebral Palsy
9.4.4. Athetoid Cerebral Palsy
9.4.5. Postnatal Cerebral Palsy
9.4.6. Congenital Cerebral Palsy
9.4.7. Hemiparesis of Cerebral Palsy
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Cerebral Palsy Market Size and Volume Forecast by End Users
9.7.1. Physiotherapy Centers
9.7.2. Hospitals
9.7.3. Specialty Clinics
9.7.4. Home Care
9.7.5. Pathology Centers
9.7.6. Ambulatory
9.7.7. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Cerebral Palsy Demand Share Forecast, 2019-2026
10. Europe Cerebral Palsy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Cerebral Palsy Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Cerebral Palsy Market Size and Volume Forecast by Types
10.4.1. Ataxia Cerebral Palsy
10.4.2. Spastic Cerebral Palsy
10.4.3. Dyskinetic Cerebral Palsy
10.4.4. Athetoid Cerebral Palsy
10.4.5. Postnatal Cerebral Palsy
10.4.6. Congenital Cerebral Palsy
10.4.7. Hemiparesis of Cerebral Palsy
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Cerebral Palsy Market Size and Volume Forecast by End Users
10.7.1. Physiotherapy Centers
10.7.2. Hospitals
10.7.3. Specialty Clinics
10.7.4. Home Care
10.7.5. Pathology Centers
10.7.6. Ambulatory
10.7.7. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Cerebral Palsy Demand Share Forecast, 2019-2026
11. Asia Pacific Cerebral Palsy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by Types
11.4.1. Ataxia Cerebral Palsy
11.4.2. Spastic Cerebral Palsy
11.4.3. Dyskinetic Cerebral Palsy
11.4.4. Athetoid Cerebral Palsy
11.4.5. Postnatal Cerebral Palsy
11.4.6. Congenital Cerebral Palsy
11.4.7. Hemiparesis of Cerebral Palsy
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by End Users
11.7.1. Physiotherapy Centers
11.7.2. Hospitals
11.7.3. Specialty Clinics
11.7.4. Home Care
11.7.5. Pathology Centers
11.7.6. Ambulatory
11.7.7. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Cerebral Palsy Demand Share Forecast, 2019-2026
12. Middle East & Africa Cerebral Palsy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by Types
12.4.1. Ataxia Cerebral Palsy
12.4.2. Spastic Cerebral Palsy
12.4.3. Dyskinetic Cerebral Palsy
12.4.4. Athetoid Cerebral Palsy
12.4.5. Postnatal Cerebral Palsy
12.4.6. Congenital Cerebral Palsy
12.4.7. Hemiparesis of Cerebral Palsy
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by End Users
12.7.1. Physiotherapy Centers
12.7.2. Hospitals
12.7.3. Specialty Clinics
12.7.4. Home Care
12.7.5. Pathology Centers
12.7.6. Ambulatory
12.7.7. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Cerebral Palsy Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Cerebral Palsy Market: Market Share Analysis
13.2. Cerebral Palsy Distributors and Customers
13.3. Cerebral Palsy Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott Laboratories
13.4.2. Allergen Plc
13.4.3. Merck & Co., Inc.
13.4.4. Medtronic PLC
13.4.5. Cellular Biomedicine Group
13.4.6. GlaxoSmithKline Plc
13.4.7. Cell Cure Neurosciences Ltd.
13.4.8. Acorda Therapeutics
Methodology
Related Reports
Some other reports from this category!
Our Clients
